cnbc.comStocks making the biggest moves midday: Figma, Joby Aviation, CommScope, Wayfair & more6 days ago
finance.yahoo.comNew BRIUMVI (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis11 months ago
finance.yahoo.comTG Therapeutics Announces Schedule of Data Presentations for BRIUMVI at the 2024 European Committee for Treatment and Research in Multiple Sclerosis Annual Meeting11 months ago
CashuTG Therapeutics Struggles After Earnings Miss, Stock Drops 15% Amid Competitive Challenges4 days ago